Amitis Saliani

Amitis Saliani

Auto-generated profile, based on publicly available information

Amitis Saliani

William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London. UK. EC1M 6BQ

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TRThomas Aleksander Ringheim-Bakka
Thomas Aleksander Ringheim-Bakka
ASAmitis Saliani
Amitis Saliani
TØTone-Kari Knutsdatter Østbye
Tone-Kari Knutsdatter Østbye
Jennifer MildenbergerJennifer Mildenberger
Jennifer Mildenberger
MDMatthew Dooley
Matthew Dooley
RGRunhild Gammelsaeter
Runhild Gammelsaeter
Psoriasis is a chronic immune-mediated inflammatory disease (IMID) affecting the skin presenting with both local and systemic inflammation as part of its pathophysiology. An oil rich in phospholipids extracted from herring roe has been shown to have immunomodulatory properties and to improve clinical symptoms and impact inflammatory cytokine pathways in psoriasis in a clinical trial. The lipidic nature of herring roe oil (HRO) and its high content of polyunsaturated fatty acids suggests involvement of lipid mediator pathways for the observed alleviation of psoriatic inflammation. Of particular interest is the super-family of lipid mediators termed specialized pro-resolving mediators (SPMs), due to their involvement in resolution of inflammation and subsequent return to homeostasis. We therefore explored the influence of HRO and its phospholipids on lipid mediator and SPM biosynthesis in IFN-γ and LPS-stimulated human monocyte-derived macrophages and an IL-17A-stimulated keratinocyte/fibroblast co-culture. Lipid mediators including SPMs were quantified from cell supernatants using a validated LC-MS/MS protocol. In these experiments we observed broad SPM biosynthesis with dominant upregulation of RvE2 and RvE3 in both cell systems and upregulation of DHA-derived SPMs such as RvD2 and PDX. Observations of PCTR2 in macrophage cell supernatants also indicate activation of reparative pathways upon treatment with HRO. In conclusion, we observed promotion of SPM biosynthesis associated with a shift towards a protective and possibly reparative macrophage phenotype as well as promotion of biosynthesis of pro-resolving lipid mediators in a skin cell co-culture, thus demonstrating a possible mechanism for resolution of inflammation in the skin niche using HRO.


4 June 2026
Verified
Dataset
Closed access
AAAyelen Artuch
Ayelen Artuch
ASAmitis Saliani
Amitis Saliani
MDMatthew Dooley
Matthew Dooley
JDJesmond Dalli
Jesmond Dalli
APAurora Pujol
Aurora Pujol